Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H29N3O |
Molecular Weight | 447.5708 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC1=CC=C(CN2N=C(C(=O)NC3=CC=CC4=CC=CC=C34)C5=C2C=CC=C5)C=C1
InChI
InChIKey=BLOQUZQMKJZVQE-UHFFFAOYSA-N
InChI=1S/C30H29N3O/c1-2-3-4-10-22-17-19-23(20-18-22)21-33-28-16-8-7-14-26(28)29(32-33)30(34)31-27-15-9-12-24-11-5-6-13-25(24)27/h5-9,11-20H,2-4,10,21H2,1H3,(H,31,34)
Molecular Formula | C30H29N3O |
Molecular Weight | 447.5708 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29549157 |
1.233 nM [EC50] | ||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29549157 |
2.028 nM [EC50] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:50:39 GMT 2023
by
admin
on
Sat Dec 16 11:50:39 GMT 2023
|
Record UNII |
GP2N1PG5X2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MN-18
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1391484-80-2
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY | |||
|
GP2N1PG5X2
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY | |||
|
MN-18
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY | MN 18 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 is banned in Sweden. | ||
|
MN-18
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY | MN-18 is a synthetic cannabinoid modeled after AKB48 (APINACA, Item No. 11566), with the adamantyl group replaced by a naphthalenyl group. The physiological and toxicological properties of this compound are unknown. This product is intended for forensic and research applications. | ||
|
DTXSID301010033
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY | |||
|
154925762
Created by
admin on Sat Dec 16 11:50:39 GMT 2023 , Edited by admin on Sat Dec 16 11:50:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |